文献速递头颈部肿瘤放疗

基于MRI的肿瘤缓解对局部复发鼻咽癌再程放疗预后价值的识别及放疗抵抗风险预测

Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma.
PubMed 文献 · Radiother Oncol · 2023-03-23

该研究回顾性纳入2010至2020年594例局部区域复发鼻咽癌患者,其中310例有完整一线治疗资料者作为次级队列。再程放疗结束时肿瘤缓解(rTR)是完全缓解(CR)患者5年总生存和局部区域控制均优于非CR患者,rTR是总生存(P=0.002)和局部区域控制(P=0.008)的独立预后因素。基于复发T分期、复发大体肿瘤体积、复发时间和初始肿瘤缓解构建的风险评分模型预测rTR的曲线下面积为0.73(95%CI:0.678至0.780),最高风险评分患者再程放疗后残留肿瘤风险为89.9%。

要点

  • 再程放疗结束时达完全缓解者5年总生存和局部区域控制优于非完全缓解者。
  • rTR是总生存(P=0.002)和局部区域控制(P=0.008)的独立预后因素。
  • 四因素风险评分模型预测rTR的曲线下面积为0.73(95%CI:0.678至0.780)。

核心结论

  • 再程放疗结束时肿瘤缓解是局部区域复发鼻咽癌患者总生存和局部区域控制的独立预后因素。
  • 作者开发了预测患者对再程放疗敏感性的风险评分模型,用于筛选放疗敏感患者,可作为临床医生的治疗决策工具。

研究设计与样本

  • 回顾性研究,纳入2010至2020年594例局部区域复发鼻咽癌患者作为总队列。
  • 其中310例具有完整一线治疗资料的患者作为次级队列。
  • 主要终点为总生存,次要终点为局部区域控制。
  • 采用多因素Cox分析探讨再程放疗结束时肿瘤缓解的预后价值,采用逻辑回归分析构建预测rTR的风险评分模型,并用受试者工作特征(ROC)分析比较其效能。

主要发现

  • 在总队列和次级队列中,再程放疗结束时达完全缓解(CR)的患者5年总生存率和局部区域控制率均高于非CR患者。
  • rTR是总生存的独立预后因素(P=0.002),也是局部区域控制的独立预后因素(P=0.008)。
  • 风险评分模型包含四个显著危险因素:复发T分期、复发大体肿瘤体积、复发时间和初始肿瘤缓解。
  • 风险评分模型的曲线下面积为0.73(95%CI:0.678至0.780),显著高于各单一变量。
  • 风险评分最高的患者可能对再程放疗不敏感,再程放疗后残留肿瘤风险为89.9%。

关键数值与推荐

  • 风险评分模型包含四个显著危险因素:复发T分期、复发大体肿瘤体积、复发时间和初始肿瘤缓解。
  • 风险评分模型预测rTR的曲线下面积为0.73(95%CI:0.678至0.780)。
  • 风险评分最高的患者再程放疗后残留肿瘤风险为89.9%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prognostic value of tumor response (TR) for locoregionally recurrent nasopharyngeal carcinoma (lrNPC) patients at the end of re-radiotherapy (re-RT) and develop a risk score model to predict patient's radiosensitivity to re-RT. MATERIALS AND METHODS: A total of 594 patients with lrNPC from 2010 to 2020 were retrospectively reviewed as the total cohort. Among these, 310 patients with complete first-line treatment data were reviewed as a secondary cohort. Overall survival (OS) was the primary endpoint. Locoregional control (LRC) was the secondary endpoint. Multivariate Cox analysis was performed to investigate the prognostic value of TR at the end of re-RT (rTR). A risk score model for predicting rTR was obtained by logistic regression analysis, and its effectiveness was compared using receiver operating characteristic (ROC) analysis. RESULTS: Patients with complete response (CR) to rTR had higher 5-year OS and LRC rate than non-CR patients in both the total and secondary cohort. rTR was an independent prognostic factor for OS (P = 0.002) and LRC (P = 0.008). We developed a risk score model including four significant risk factors (relapse T stage, relapse gross tumor volume, time to recurrence, and initial TR). The area under the curve of the risk score model was 0.73 (95% CI: 0.678 to 0.780), which was significantly higher than that of each variable alone. Patients with the highest risk scores may be insensitive to re-RT and had a residual tumor risk of 89.9% after rRT. CONCLUSION: rTR was an independent prognostic factor for OS and LRC in lrNPC patients. We developed a risk score model for predicting patients' sensitivity to re-RT to screen for radiosensitive patients. This can serve as a treatment decision-making tool for clinicians.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lu ZJ, Liu T, Lin JY, et al. Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2023. PMID: 36963444. doi:10.1016/j.radonc.2023.109635

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。